Search Results - "Etuk, Annie"
-
1
Phase 1 clinical trial of CRISPR-engineered CAR19 universal T cells for treatment of children with refractory B cell leukemia
Published in Science translational medicine (26-10-2022)“…Genome editing of allogeneic T cells can provide "off-the-shelf" alternatives to autologous chimeric antigen receptor (CAR) T cell therapies. Disruption of T…”
Get more information
Journal Article -
2
Umbilical cord blood T cells can be isolated and enriched by CD62L selection for use in 'off the shelf' chimeric antigen receptor T-cell therapies to widen transplant options
Published in Haematologica (Roma) (11-07-2024)“…Umbilical cord blood (UCB) T cells exhibit distinct naive ontogenetic profiles and may be an attractive source of starting cells for the production of chimeric…”
Get full text
Journal Article -
3
Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia
Published in The New England journal of medicine (07-09-2023)“…Three patients with T-cell ALL were treated with allogeneic CAR T cells that were base-edited to prevent CAR T-cell fratricide and graft-versus-host disease…”
Get full text
Journal Article -
4
Universal' Fratricide-Resistant CAR T Cells Against T Cell Leukemia Generated By Coupled & Uncoupled Deamination Mediated Base Editing
Published in Blood (13-11-2019)“…Chimeric antigen receptor (CAR) T cell approaches to target T cell malignancies have been hampered by the fundamental issue of ‘T v T’ fratricide when T…”
Get full text
Journal Article -
5
Single and Combinational Multiplex Base-Edited 'Universal' CAR T Cells in a Humanised Model of Primary CD7+CD33+ AML
Published in Blood (15-11-2022)Get full text
Journal Article -
6
TT52CAR19: Phase 1 Trial of CRISPR/Cas9 Edited Allogeneic CAR19 T Cells for Paediatric Relapsed/Refractory B-ALL
Published in Blood (23-11-2021)“…Background ‘Off-the-shelf’ CAR T cell therapies are being investigated as alternatives to autologous CAR therapy, and can be generated using genome editing…”
Get full text
Journal Article -
7
Tvt CAR7: Phase 1 Clinical Trial of Base-Edited "Universal” CAR7 T Cells for Paediatric Relapsed/Refractory T-ALL
Published in Blood (15-11-2022)Get full text
Journal Article